Rank | Gene Set | Z-score |
---|---|---|
1 | fatty acid elongation (GO:0030497) | 6.81273098 |
2 | ensheathment of neurons (GO:0007272) | 6.46330960 |
3 | axon ensheathment (GO:0008366) | 6.46330960 |
4 | myelination (GO:0042552) | 6.41880741 |
5 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.66250503 |
6 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.28331005 |
7 | water-soluble vitamin biosynthetic process (GO:0042364) | 5.10595669 |
8 | negative regulation of neurotransmitter transport (GO:0051589) | 4.88469420 |
9 | myelin maintenance (GO:0043217) | 4.83488260 |
10 | presynaptic membrane organization (GO:0097090) | 4.76136991 |
11 | apical protein localization (GO:0045176) | 4.69124305 |
12 | protein complex biogenesis (GO:0070271) | 4.64838456 |
13 | presynaptic membrane assembly (GO:0097105) | 4.62433369 |
14 | behavioral response to nicotine (GO:0035095) | 4.61755995 |
15 | oligodendrocyte differentiation (GO:0048709) | 4.56336242 |
16 | sulfation (GO:0051923) | 4.46925089 |
17 | negative regulation of protein localization to cell surface (GO:2000009) | 4.35776689 |
18 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.22603036 |
19 | NADH dehydrogenase complex assembly (GO:0010257) | 4.22603036 |
20 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.22603036 |
21 | regulation of collateral sprouting (GO:0048670) | 4.21628410 |
22 | negative regulation of membrane potential (GO:0045837) | 4.21250386 |
23 | asymmetric protein localization (GO:0008105) | 4.20300342 |
24 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.19183401 |
25 | establishment of mitochondrion localization (GO:0051654) | 4.18943426 |
26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.18107321 |
27 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.07490392 |
28 | adhesion of symbiont to host cell (GO:0044650) | 4.06595388 |
29 | virion attachment to host cell (GO:0019062) | 4.06595388 |
30 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.99435618 |
31 | interferon-gamma secretion (GO:0072643) | 3.96606032 |
32 | astrocyte development (GO:0014002) | 3.93411272 |
33 | regulation of germinal center formation (GO:0002634) | 3.89632809 |
34 | photoreceptor cell differentiation (GO:0046530) | 3.87588961 |
35 | eye photoreceptor cell differentiation (GO:0001754) | 3.87588961 |
36 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.80394442 |
37 | creatine metabolic process (GO:0006600) | 3.78316329 |
38 | adaptation of signaling pathway (GO:0023058) | 3.75063514 |
39 | glycerophospholipid catabolic process (GO:0046475) | 3.74140062 |
40 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.69581927 |
41 | neuron cell-cell adhesion (GO:0007158) | 3.66899977 |
42 | DNA deamination (GO:0045006) | 3.66616039 |
43 | L-amino acid import (GO:0043092) | 3.64862112 |
44 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.62396082 |
45 | negative regulation of mast cell activation (GO:0033004) | 3.62034685 |
46 | response to xenobiotic stimulus (GO:0009410) | 3.60564712 |
47 | substantia nigra development (GO:0021762) | 3.55120637 |
48 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.54601600 |
49 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.54601600 |
50 | neuronal action potential propagation (GO:0019227) | 3.51222381 |
51 | regulation of glomerulus development (GO:0090192) | 3.50311661 |
52 | endoderm formation (GO:0001706) | 3.49854372 |
53 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.49189664 |
54 | cholesterol biosynthetic process (GO:0006695) | 3.48771910 |
55 | cellular response to ATP (GO:0071318) | 3.48554900 |
56 | positive regulation of action potential (GO:0045760) | 3.48374685 |
57 | import into cell (GO:0098657) | 3.47454063 |
58 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.43503090 |
59 | positive regulation of fatty acid transport (GO:2000193) | 3.40052698 |
60 | response to methylmercury (GO:0051597) | 3.37179455 |
61 | adult walking behavior (GO:0007628) | 3.36802570 |
62 | base-excision repair, AP site formation (GO:0006285) | 3.36573112 |
63 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.36012653 |
64 | cellular response to exogenous dsRNA (GO:0071360) | 3.31367619 |
65 | prostate gland growth (GO:0060736) | 3.24283274 |
66 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.24042786 |
67 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.21029256 |
68 | membrane tubulation (GO:0097320) | 3.16363741 |
69 | membrane repolarization during action potential (GO:0086011) | 3.16097346 |
70 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.16012056 |
71 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.15263304 |
72 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.15075326 |
73 | peripheral nervous system axon ensheathment (GO:0032292) | 3.13926147 |
74 | myelination in peripheral nervous system (GO:0022011) | 3.13926147 |
75 | limb bud formation (GO:0060174) | 3.13858475 |
76 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.13654268 |
77 | amyloid precursor protein metabolic process (GO:0042982) | 3.13374328 |
78 | cerebellar granule cell differentiation (GO:0021707) | 3.13064322 |
79 | indolalkylamine metabolic process (GO:0006586) | 3.11885664 |
80 | positive regulation of glomerulus development (GO:0090193) | 3.10482160 |
81 | cell proliferation in forebrain (GO:0021846) | 3.10415939 |
82 | negative regulation of axonogenesis (GO:0050771) | 3.08894232 |
83 | negative regulation of JUN kinase activity (GO:0043508) | 3.08415968 |
84 | protein polyglutamylation (GO:0018095) | 3.07534625 |
85 | neuron remodeling (GO:0016322) | 3.06393629 |
86 | transmission of nerve impulse (GO:0019226) | 3.06151096 |
87 | response to redox state (GO:0051775) | 3.04447578 |
88 | sterol biosynthetic process (GO:0016126) | 3.02588010 |
89 | ovulation cycle (GO:0042698) | 2.99947458 |
90 | adhesion of symbiont to host (GO:0044406) | 2.99342268 |
91 | positive regulation of defense response to virus by host (GO:0002230) | 2.99010540 |
92 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.98970830 |
93 | ear development (GO:0043583) | 2.97395461 |
94 | glycosylceramide metabolic process (GO:0006677) | 2.97161026 |
95 | protein K48-linked deubiquitination (GO:0071108) | 2.96766771 |
96 | regulation of endothelial cell differentiation (GO:0045601) | 2.96526340 |
97 | regulation of receptor binding (GO:1900120) | 2.95824121 |
98 | membrane assembly (GO:0071709) | 2.95709777 |
99 | protein palmitoylation (GO:0018345) | 2.94797903 |
100 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.93424968 |
101 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.93197781 |
102 | magnesium ion transport (GO:0015693) | 2.92718533 |
103 | somite development (GO:0061053) | 2.90513926 |
104 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.87894677 |
105 | neuronal ion channel clustering (GO:0045161) | 2.87025610 |
106 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.85384133 |
107 | kynurenine metabolic process (GO:0070189) | 2.85269629 |
108 | serotonin metabolic process (GO:0042428) | 2.85237262 |
109 | gamma-aminobutyric acid transport (GO:0015812) | 2.84852536 |
110 | axon development (GO:0061564) | 2.84424037 |
111 | dentate gyrus development (GO:0021542) | 2.83449598 |
112 | vitamin biosynthetic process (GO:0009110) | 2.81730824 |
113 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.80916505 |
114 | amino acid import (GO:0043090) | 2.79760559 |
115 | peripheral nervous system development (GO:0007422) | 2.79292629 |
116 | cellular response to epinephrine stimulus (GO:0071872) | 2.78204555 |
117 | response to gravity (GO:0009629) | 2.76109385 |
118 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.75798983 |
119 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.75007881 |
120 | isoprenoid biosynthetic process (GO:0008299) | 2.74929899 |
121 | primary amino compound metabolic process (GO:1901160) | 2.74691205 |
122 | tryptophan catabolic process (GO:0006569) | 2.74123730 |
123 | indole-containing compound catabolic process (GO:0042436) | 2.74123730 |
124 | indolalkylamine catabolic process (GO:0046218) | 2.74123730 |
125 | regulation of lipoprotein metabolic process (GO:0050746) | 2.73788489 |
126 | regulation of mesoderm development (GO:2000380) | 2.73652327 |
127 | platelet dense granule organization (GO:0060155) | 2.72069923 |
128 | positive regulation of prostaglandin secretion (GO:0032308) | 2.71874517 |
129 | neurotransmitter uptake (GO:0001504) | 2.71391114 |
130 | nucleotide transmembrane transport (GO:1901679) | 2.70589300 |
131 | response to epinephrine (GO:0071871) | 2.70132679 |
132 | pharyngeal system development (GO:0060037) | 2.69655026 |
133 | regulation of cholesterol storage (GO:0010885) | 2.67834051 |
134 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.67686571 |
135 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.67671466 |
136 | GPI anchor biosynthetic process (GO:0006506) | 2.63087295 |
137 | GPI anchor metabolic process (GO:0006505) | 2.61432192 |
138 | negative regulation of axon extension (GO:0030517) | 2.61347628 |
139 | protein import into peroxisome matrix (GO:0016558) | 2.60197607 |
140 | negative regulation of inclusion body assembly (GO:0090084) | 2.60177256 |
141 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.58185824 |
142 | neuron recognition (GO:0008038) | 2.57795755 |
143 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.57411205 |
144 | organ growth (GO:0035265) | 2.57410842 |
145 | indole-containing compound metabolic process (GO:0042430) | 2.55713090 |
146 | peptidyl-cysteine modification (GO:0018198) | 2.55437726 |
147 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.54552721 |
148 | Golgi to endosome transport (GO:0006895) | 2.54358169 |
149 | positive regulation of icosanoid secretion (GO:0032305) | 2.54290504 |
150 | regulation of skeletal muscle contraction (GO:0014819) | 2.54122292 |
151 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.51975146 |
152 | response to lipoprotein particle (GO:0055094) | 2.51729540 |
153 | interferon-gamma production (GO:0032609) | 2.49795601 |
154 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.49132668 |
155 | axonemal dynein complex assembly (GO:0070286) | 2.48354628 |
156 | negative regulation of lipid storage (GO:0010888) | 2.48194852 |
157 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.47645262 |
158 | mechanosensory behavior (GO:0007638) | 2.47036752 |
159 | parturition (GO:0007567) | 2.46663542 |
160 | glial cell differentiation (GO:0010001) | 2.45486338 |
161 | axoneme assembly (GO:0035082) | 2.45270611 |
162 | cytochrome complex assembly (GO:0017004) | 2.45227770 |
163 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.44837764 |
164 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.44393054 |
165 | glial cell development (GO:0021782) | 2.44356566 |
166 | dendritic spine morphogenesis (GO:0060997) | 2.44070603 |
167 | cellular potassium ion homeostasis (GO:0030007) | 2.43315938 |
168 | negative regulation of synaptic transmission (GO:0050805) | 2.42590354 |
169 | neural nucleus development (GO:0048857) | 2.41495147 |
170 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.41415878 |
171 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.41415878 |
172 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.41073014 |
173 | epithelial cilium movement (GO:0003351) | 2.40825043 |
174 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.40441868 |
175 | response to monoamine (GO:0071867) | 2.39831659 |
176 | response to catecholamine (GO:0071869) | 2.39831659 |
177 | regulation of cilium movement (GO:0003352) | 2.38467941 |
178 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.38439485 |
179 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.37377600 |
180 | cellular anion homeostasis (GO:0030002) | 2.37332042 |
181 | negative regulation of appetite (GO:0032099) | 2.37007535 |
182 | negative regulation of response to food (GO:0032096) | 2.37007535 |
183 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.36799248 |
184 | negative regulation of blood pressure (GO:0045776) | 2.36510944 |
185 | positive regulation of glial cell differentiation (GO:0045687) | 2.36209567 |
186 | cellular response to catecholamine stimulus (GO:0071870) | 2.34521595 |
187 | smooth muscle tissue development (GO:0048745) | 2.32206409 |
188 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.31164460 |
189 | positive regulation of fatty acid oxidation (GO:0046321) | 2.30760230 |
190 | auditory behavior (GO:0031223) | 2.29570605 |
191 | cobalamin metabolic process (GO:0009235) | 2.28251729 |
192 | positive regulation of heat generation (GO:0031652) | 2.27727253 |
193 | detection of light stimulus involved in visual perception (GO:0050908) | 2.27670616 |
194 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.27670616 |
195 | central nervous system myelination (GO:0022010) | 10.2443909 |
196 | axon ensheathment in central nervous system (GO:0032291) | 10.2443909 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.69035833 |
2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.38706041 |
3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.10337361 |
4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.57784118 |
5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.55766648 |
6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.50644015 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.50615562 |
8 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.42360567 |
9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.40472369 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37680995 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35648420 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.35305326 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.20546929 |
14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.20546929 |
15 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.20483959 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.15441184 |
17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.10153706 |
18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07172519 |
19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01415089 |
20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00502632 |
21 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00456557 |
22 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00105157 |
23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99521716 |
24 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.99183611 |
25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99169819 |
26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.95678862 |
27 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95277364 |
28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.89839373 |
29 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.85724212 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84889117 |
31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83616505 |
32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77297521 |
33 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.72482833 |
34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.71764174 |
35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70906053 |
36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.70522960 |
37 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68669797 |
38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68081736 |
39 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66498461 |
40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60982976 |
41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.60384962 |
42 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.57262398 |
43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54778109 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54762067 |
45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54423348 |
46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51739835 |
47 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50458470 |
48 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.50264729 |
49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50099394 |
50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.49528843 |
51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49482954 |
52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.49124876 |
53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.48474980 |
54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47205679 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44886961 |
56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44043907 |
57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43095677 |
58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.42442054 |
59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40334512 |
60 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39993589 |
61 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36695621 |
62 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.35470387 |
63 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.34795179 |
64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32261316 |
65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30990866 |
66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28409030 |
67 | NCOR_22424771_ChIP-Seq_293T_Human | 1.27944846 |
68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27873304 |
69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27547926 |
70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26850705 |
71 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26020419 |
72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24547203 |
73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22881163 |
74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.22818890 |
75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.22059889 |
76 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.21917217 |
77 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.20364806 |
78 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.19817541 |
79 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19107954 |
80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18784137 |
81 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17250035 |
82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17250035 |
83 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16330886 |
84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16195279 |
85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16118586 |
86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14626633 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13534923 |
88 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12248219 |
89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.11242928 |
90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10464858 |
91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09897350 |
92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09819962 |
93 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09371452 |
94 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09195063 |
95 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08598204 |
96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08425218 |
97 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07084937 |
98 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06710534 |
99 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06710534 |
100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04866517 |
101 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04741731 |
102 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03834267 |
103 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03650381 |
104 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03650381 |
105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03650058 |
106 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.03123317 |
107 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02937407 |
108 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02192247 |
109 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00728970 |
110 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00627779 |
111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00207431 |
112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99710965 |
113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99533337 |
114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98348586 |
115 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97597558 |
116 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97555478 |
117 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96819109 |
118 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.96687418 |
119 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96613725 |
120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96184470 |
121 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95544878 |
122 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95534069 |
123 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.94203042 |
124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94171999 |
125 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93814912 |
126 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93619065 |
127 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93068973 |
128 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92372494 |
129 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.92311562 |
130 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92102583 |
131 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92068880 |
132 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91992923 |
133 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.91776021 |
134 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91486983 |
135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90823669 |
136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90581732 |
137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90388943 |
138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89878273 |
139 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.89728118 |
140 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88959966 |
141 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88675052 |
142 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88663627 |
143 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.88628600 |
144 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.88475865 |
145 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.88400142 |
146 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87503042 |
147 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87442580 |
148 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.86340588 |
149 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86299321 |
150 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86122288 |
151 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85561679 |
152 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85556783 |
153 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85210870 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 5.07801305 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 4.93923796 |
3 | MP0000920_abnormal_myelination | 4.84698892 |
4 | MP0003880_abnormal_central_pattern | 4.35495221 |
5 | MP0004270_analgesia | 3.67411953 |
6 | MP0003011_delayed_dark_adaptation | 3.11177254 |
7 | MP0003329_amyloid_beta_deposits | 2.87278660 |
8 | MP0003950_abnormal_plasma_membrane | 2.80860466 |
9 | MP0003690_abnormal_glial_cell | 2.75935061 |
10 | MP0002272_abnormal_nervous_system | 2.64393665 |
11 | MP0004859_abnormal_synaptic_plasticity | 2.63324468 |
12 | MP0005171_absent_coat_pigmentation | 2.52602395 |
13 | MP0001486_abnormal_startle_reflex | 2.51429849 |
14 | MP0001529_abnormal_vocalization | 2.50899220 |
15 | MP0004885_abnormal_endolymph | 2.50504141 |
16 | MP0001905_abnormal_dopamine_level | 2.47231489 |
17 | MP0002064_seizures | 2.46859661 |
18 | MP0001485_abnormal_pinna_reflex | 2.45569895 |
19 | MP0004742_abnormal_vestibular_system | 2.43760256 |
20 | MP0005670_abnormal_white_adipose | 2.33617232 |
21 | MP0009046_muscle_twitch | 2.30215783 |
22 | MP0003136_yellow_coat_color | 2.23296342 |
23 | MP0002138_abnormal_hepatobiliary_system | 2.20395938 |
24 | MP0003634_abnormal_glial_cell | 2.18045048 |
25 | MP0005671_abnormal_response_to | 2.15169472 |
26 | MP0000778_abnormal_nervous_system | 2.13597320 |
27 | MP0003724_increased_susceptibility_to | 2.11897124 |
28 | MP0009745_abnormal_behavioral_response | 2.11189309 |
29 | MP0003635_abnormal_synaptic_transmissio | 2.10936700 |
30 | MP0004142_abnormal_muscle_tone | 2.04408769 |
31 | MP0004147_increased_porphyrin_level | 1.99529796 |
32 | MP0002734_abnormal_mechanical_nocicepti | 1.96122896 |
33 | MP0002148_abnormal_hypersensitivity_rea | 1.91618204 |
34 | MP0005623_abnormal_meninges_morphology | 1.85712277 |
35 | MP0005409_darkened_coat_color | 1.77965984 |
36 | MP0002229_neurodegeneration | 1.77525868 |
37 | MP0003632_abnormal_nervous_system | 1.74987032 |
38 | MP0009764_decreased_sensitivity_to | 1.72802857 |
39 | MP0005423_abnormal_somatic_nervous | 1.69248758 |
40 | MP0002572_abnormal_emotion/affect_behav | 1.63900429 |
41 | MP0002160_abnormal_reproductive_system | 1.61144607 |
42 | MP0004130_abnormal_muscle_cell | 1.59101861 |
43 | MP0001440_abnormal_grooming_behavior | 1.57805069 |
44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.55698987 |
45 | MP0004043_abnormal_pH_regulation | 1.55037029 |
46 | MP0002063_abnormal_learning/memory/cond | 1.54689201 |
47 | MP0005389_reproductive_system_phenotype | 1.54437760 |
48 | MP0010678_abnormal_skin_adnexa | 1.53540683 |
49 | MP0001853_heart_inflammation | 1.51959856 |
50 | MP0005410_abnormal_fertilization | 1.50362907 |
51 | MP0000537_abnormal_urethra_morphology | 1.49272940 |
52 | MP0000343_altered_response_to | 1.48903896 |
53 | MP0001963_abnormal_hearing_physiology | 1.46802231 |
54 | MP0008775_abnormal_heart_ventricle | 1.46211043 |
55 | MP0002067_abnormal_sensory_capabilities | 1.44908023 |
56 | MP0004185_abnormal_adipocyte_glucose | 1.44451064 |
57 | MP0004924_abnormal_behavior | 1.43615672 |
58 | MP0005386_behavior/neurological_phenoty | 1.43615672 |
59 | MP0002653_abnormal_ependyma_morphology | 1.43497966 |
60 | MP0000383_abnormal_hair_follicle | 1.42709976 |
61 | MP0002277_abnormal_respiratory_mucosa | 1.42126977 |
62 | MP0001970_abnormal_pain_threshold | 1.42026570 |
63 | MP0008789_abnormal_olfactory_epithelium | 1.41163841 |
64 | MP0005551_abnormal_eye_electrophysiolog | 1.39278756 |
65 | MP0003631_nervous_system_phenotype | 1.38201747 |
66 | MP0002882_abnormal_neuron_morphology | 1.37777669 |
67 | MP0000955_abnormal_spinal_cord | 1.36839542 |
68 | MP0000604_amyloidosis | 1.35972279 |
69 | MP0000462_abnormal_digestive_system | 1.32307474 |
70 | MP0002733_abnormal_thermal_nociception | 1.31443596 |
71 | MP0005084_abnormal_gallbladder_morpholo | 1.31316005 |
72 | MP0008569_lethality_at_weaning | 1.30874708 |
73 | MP0006292_abnormal_olfactory_placode | 1.30437424 |
74 | MP0005253_abnormal_eye_physiology | 1.29771495 |
75 | MP0008872_abnormal_physiological_respon | 1.26581684 |
76 | MP0002066_abnormal_motor_capabilities/c | 1.25777662 |
77 | MP0002735_abnormal_chemical_nociception | 1.22364853 |
78 | MP0000049_abnormal_middle_ear | 1.22251256 |
79 | MP0004272_abnormal_basement_membrane | 1.22224594 |
80 | MP0005000_abnormal_immune_tolerance | 1.21422392 |
81 | MP0002876_abnormal_thyroid_physiology | 1.20427578 |
82 | MP0003633_abnormal_nervous_system | 1.18913430 |
83 | MP0004381_abnormal_hair_follicle | 1.17904993 |
84 | MP0001919_abnormal_reproductive_system | 1.16346833 |
85 | MP0000685_abnormal_immune_system | 1.14931646 |
86 | MP0002752_abnormal_somatic_nervous | 1.14560513 |
87 | MP0001968_abnormal_touch/_nociception | 1.14129819 |
88 | MP0003123_paternal_imprinting | 1.13703768 |
89 | MP0002139_abnormal_hepatobiliary_system | 1.11934296 |
90 | MP0009785_altered_susceptibility_to | 1.10685751 |
91 | MP0009765_abnormal_xenobiotic_induced | 1.09460919 |
92 | MP0001790_abnormal_immune_system | 1.08219990 |
93 | MP0005387_immune_system_phenotype | 1.08219990 |
94 | MP0004145_abnormal_muscle_electrophysio | 1.08124511 |
95 | MP0005167_abnormal_blood-brain_barrier | 1.06547141 |
96 | MP0001501_abnormal_sleep_pattern | 1.03744994 |
97 | MP0000230_abnormal_systemic_arterial | 1.03193180 |
98 | MP0005058_abnormal_lysosome_morphology | 1.01277557 |
99 | MP0004134_abnormal_chest_morphology | 1.00222537 |
100 | MP0000747_muscle_weakness | 0.98480865 |
101 | MP0000026_abnormal_inner_ear | 0.96184003 |
102 | MP0001299_abnormal_eye_distance/ | 0.96054259 |
103 | MP0003938_abnormal_ear_development | 0.92325510 |
104 | MP0002736_abnormal_nociception_after | 0.91677914 |
105 | MP0006082_CNS_inflammation | 0.91203622 |
106 | MP0009053_abnormal_anal_canal | 0.90963976 |
107 | MP0002557_abnormal_social/conspecific_i | 0.90742701 |
108 | MP0001835_abnormal_antigen_presentation | 0.90630699 |
109 | MP0005195_abnormal_posterior_eye | 0.90542614 |
110 | MP0001800_abnormal_humoral_immune | 0.90263842 |
111 | MP0003890_abnormal_embryonic-extraembry | 0.90065773 |
112 | MP0005646_abnormal_pituitary_gland | 0.89224335 |
113 | MP0000538_abnormal_urinary_bladder | 0.89011380 |
114 | MP0002184_abnormal_innervation | 0.88389287 |
115 | MP0002638_abnormal_pupillary_reflex | 0.87890944 |
116 | MP0001851_eye_inflammation | 0.87369770 |
117 | MP0002152_abnormal_brain_morphology | 0.87312733 |
118 | MP0008877_abnormal_DNA_methylation | 0.86831308 |
119 | MP0002452_abnormal_antigen_presenting | 0.86796365 |
120 | MP0000631_abnormal_neuroendocrine_gland | 0.86795329 |
121 | MP0003879_abnormal_hair_cell | 0.85540913 |
122 | MP0002723_abnormal_immune_serum | 0.84842942 |
123 | MP0005451_abnormal_body_composition | 0.84442732 |
124 | MP0001346_abnormal_lacrimal_gland | 0.83794598 |
125 | MP0001188_hyperpigmentation | 0.83659645 |
126 | MP0003283_abnormal_digestive_organ | 0.82944861 |
127 | MP0000762_abnormal_tongue_morphology | 0.82802202 |
128 | MP0002295_abnormal_pulmonary_circulatio | 0.81468862 |
129 | MP0002928_abnormal_bile_duct | 0.81036866 |
130 | MP0002932_abnormal_joint_morphology | 0.80300787 |
131 | MP0008260_abnormal_autophagy | 0.79719014 |
132 | MP0005367_renal/urinary_system_phenotyp | 0.77437298 |
133 | MP0000516_abnormal_urinary_system | 0.77437298 |
134 | MP0003638_abnormal_response/metabolism_ | 0.77343304 |
135 | MP0001756_abnormal_urination | 0.76846057 |
136 | MP0001765_abnormal_ion_homeostasis | 0.76369727 |
137 | MP0004036_abnormal_muscle_relaxation | 0.75874951 |
138 | MP0000566_synostosis | 0.75823193 |
139 | MP0004858_abnormal_nervous_system | 0.75384159 |
140 | MP0004085_abnormal_heartbeat | 0.74812209 |
141 | MP0001533_abnormal_skeleton_physiology | 0.74678466 |
142 | MP0002163_abnormal_gland_morphology | 0.74566463 |
143 | MP0001348_abnormal_lacrimal_gland | 0.74541665 |
144 | MP0003119_abnormal_digestive_system | 0.72426155 |
145 | MP0005025_abnormal_response_to | 0.72355083 |
146 | MP0005647_abnormal_sex_gland | 0.71914653 |
147 | MP0005310_abnormal_salivary_gland | 0.71828088 |
148 | MP0006072_abnormal_retinal_apoptosis | 0.71665213 |
149 | MP0003137_abnormal_impulse_conducting | 0.71540800 |
150 | MP0001177_atelectasis | 0.70041006 |
151 | MP0001502_abnormal_circadian_rhythm | 0.67800516 |
152 | MP0003937_abnormal_limbs/digits/tail_de | 0.67578713 |
153 | MP0004811_abnormal_neuron_physiology | 0.67401591 |
154 | MP0004133_heterotaxia | 0.66877165 |
155 | MP0000013_abnormal_adipose_tissue | 0.65835317 |
156 | MP0009780_abnormal_chondrocyte_physiolo | 0.65437327 |
157 | MP0002102_abnormal_ear_morphology | 0.65226640 |
158 | MP0009384_cardiac_valve_regurgitation | 0.64428477 |
159 | MP0000372_irregular_coat_pigmentation | 0.64260819 |
160 | MP0001984_abnormal_olfaction | 0.64053244 |
161 | MP0003195_calcinosis | 0.63482898 |
162 | MP0003806_abnormal_nucleotide_metabolis | 0.63396996 |
163 | MP0000749_muscle_degeneration | 0.63229211 |
164 | MP0005408_hypopigmentation | 0.62578414 |
165 | MP0000467_abnormal_esophagus_morphology | 0.59986165 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.59745483 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.59745483 |
3 | Neurofibrillary tangles (HP:0002185) | 5.85928875 |
4 | Parakeratosis (HP:0001036) | 5.54109338 |
5 | Cutaneous melanoma (HP:0012056) | 5.46316729 |
6 | Abnormality of the corticospinal tract (HP:0002492) | 5.00790134 |
7 | Cerebral inclusion bodies (HP:0100314) | 4.29202406 |
8 | Sensory axonal neuropathy (HP:0003390) | 4.20402397 |
9 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.01390638 |
10 | Peripheral hypomyelination (HP:0007182) | 4.01193041 |
11 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.65925131 |
12 | Short femoral neck (HP:0100864) | 3.55078837 |
13 | Meningioma (HP:0002858) | 3.54239017 |
14 | Supranuclear gaze palsy (HP:0000605) | 3.48136623 |
15 | Methylmalonic aciduria (HP:0012120) | 3.43825119 |
16 | Spastic gait (HP:0002064) | 3.43429315 |
17 | Congenital, generalized hypertrichosis (HP:0004540) | 3.28784448 |
18 | Hypoplasia of the uterus (HP:0000013) | 3.28063783 |
19 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 3.27683804 |
20 | Congenital stationary night blindness (HP:0007642) | 3.26323188 |
21 | Scanning speech (HP:0002168) | 3.19139074 |
22 | Ankle clonus (HP:0011448) | 3.14055149 |
23 | Cerebral hypomyelination (HP:0006808) | 3.12427812 |
24 | Onion bulb formation (HP:0003383) | 3.12091868 |
25 | Myokymia (HP:0002411) | 3.11218815 |
26 | Increased serum pyruvate (HP:0003542) | 3.11095924 |
27 | Abnormality of glycolysis (HP:0004366) | 3.11095924 |
28 | Insidious onset (HP:0003587) | 3.08656124 |
29 | Termporal pattern (HP:0011008) | 3.08656124 |
30 | Dysmetria (HP:0001310) | 3.05063179 |
31 | Abolished electroretinogram (ERG) (HP:0000550) | 3.02801413 |
32 | Pendular nystagmus (HP:0012043) | 3.00799478 |
33 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.99510304 |
34 | Thickened helices (HP:0000391) | 2.99144515 |
35 | Alacrima (HP:0000522) | 2.97314628 |
36 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.94228002 |
37 | Akinesia (HP:0002304) | 2.92149595 |
38 | Intention tremor (HP:0002080) | 2.88323733 |
39 | Atonic seizures (HP:0010819) | 2.83594330 |
40 | Nephronophthisis (HP:0000090) | 2.80958289 |
41 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.78035449 |
42 | Pancreatic cysts (HP:0001737) | 2.72862825 |
43 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.71039151 |
44 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.70926614 |
45 | Short 1st metacarpal (HP:0010034) | 2.70926614 |
46 | Focal motor seizures (HP:0011153) | 2.69008077 |
47 | Hyperglycinemia (HP:0002154) | 2.68297383 |
48 | Absent/shortened dynein arms (HP:0200106) | 2.67969903 |
49 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.67969903 |
50 | Hematochezia (HP:0002573) | 2.67355601 |
51 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.65757776 |
52 | Epileptic encephalopathy (HP:0200134) | 2.65523378 |
53 | Molar tooth sign on MRI (HP:0002419) | 2.64967508 |
54 | Abnormality of midbrain morphology (HP:0002418) | 2.64967508 |
55 | Hyperventilation (HP:0002883) | 2.64918450 |
56 | Leukodystrophy (HP:0002415) | 2.64823732 |
57 | Congenital sensorineural hearing impairment (HP:0008527) | 2.61219423 |
58 | True hermaphroditism (HP:0010459) | 2.60902093 |
59 | Abnormal auditory evoked potentials (HP:0006958) | 2.60496505 |
60 | Abnormality of the 1st metacarpal (HP:0010009) | 2.59958638 |
61 | Pancreatic fibrosis (HP:0100732) | 2.59248506 |
62 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.57091189 |
63 | Short hallux (HP:0010109) | 2.53862576 |
64 | Retinal dysplasia (HP:0007973) | 2.53153381 |
65 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.51898417 |
66 | Autoamputation (HP:0001218) | 2.50319924 |
67 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.48607627 |
68 | Agitation (HP:0000713) | 2.47869854 |
69 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.47116058 |
70 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.46391228 |
71 | Pheochromocytoma (HP:0002666) | 2.43082644 |
72 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.42674458 |
73 | Clumsiness (HP:0002312) | 2.41157853 |
74 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.36754130 |
75 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.36754130 |
76 | Decreased circulating renin level (HP:0003351) | 2.35650022 |
77 | Split foot (HP:0001839) | 2.34536926 |
78 | Asplenia (HP:0001746) | 2.30991480 |
79 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.30797366 |
80 | Cerebral hemorrhage (HP:0001342) | 2.30541241 |
81 | Adactyly (HP:0009776) | 2.29625906 |
82 | Hypoplasia of the iris (HP:0007676) | 2.28661931 |
83 | Anteriorly placed anus (HP:0001545) | 2.27753913 |
84 | Short tibia (HP:0005736) | 2.27726835 |
85 | Spastic paraparesis (HP:0002313) | 2.26912637 |
86 | Abnormality of glycolipid metabolism (HP:0010969) | 2.26881308 |
87 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.26881308 |
88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.26881308 |
89 | Genetic anticipation (HP:0003743) | 2.25491101 |
90 | Hypoplastic pelvis (HP:0008839) | 2.24874682 |
91 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.24503311 |
92 | Abnormality of the renal medulla (HP:0100957) | 2.23998007 |
93 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.23086388 |
94 | Decreased lacrimation (HP:0000633) | 2.20830159 |
95 | Humeroradial synostosis (HP:0003041) | 2.20576933 |
96 | Synostosis involving the elbow (HP:0003938) | 2.20576933 |
97 | Megalencephaly (HP:0001355) | 2.20394575 |
98 | IgG deficiency (HP:0004315) | 2.19672213 |
99 | Lower limb muscle weakness (HP:0007340) | 2.19211748 |
100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18989739 |
101 | Slow saccadic eye movements (HP:0000514) | 2.18943138 |
102 | Neuroendocrine neoplasm (HP:0100634) | 2.18535146 |
103 | Stridor (HP:0010307) | 2.17634718 |
104 | Vacuolated lymphocytes (HP:0001922) | 2.16706363 |
105 | Conjunctival hamartoma (HP:0100780) | 2.16332179 |
106 | Stenosis of the external auditory canal (HP:0000402) | 2.15341234 |
107 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.14659925 |
108 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.14650281 |
109 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.14319603 |
110 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.12821490 |
111 | Bone cyst (HP:0012062) | 2.11673848 |
112 | Abnormal ciliary motility (HP:0012262) | 2.11055209 |
113 | Visual hallucinations (HP:0002367) | 2.10023349 |
114 | Methylmalonic acidemia (HP:0002912) | 2.08963931 |
115 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.08491561 |
116 | Aplasia of the phalanges of the hand (HP:0009802) | 2.08491561 |
117 | Aplasia involving bones of the extremities (HP:0009825) | 2.08491561 |
118 | Muscle fiber splitting (HP:0003555) | 2.08478042 |
119 | Morphological abnormality of the inner ear (HP:0011390) | 2.06281143 |
120 | Abnormal drinking behavior (HP:0030082) | 2.05987437 |
121 | Polydipsia (HP:0001959) | 2.05987437 |
122 | Absent septum pellucidum (HP:0001331) | 2.05623632 |
123 | Progressive cerebellar ataxia (HP:0002073) | 2.04841689 |
124 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.04074866 |
125 | Dysostosis multiplex (HP:0000943) | 2.04071046 |
126 | Broad-based gait (HP:0002136) | 2.01915687 |
127 | Prostate neoplasm (HP:0100787) | 2.01067257 |
128 | Gaze-evoked nystagmus (HP:0000640) | 2.00848855 |
129 | Diplopia (HP:0000651) | 1.99023134 |
130 | Abnormality of binocular vision (HP:0011514) | 1.99023134 |
131 | Partial agenesis of the corpus callosum (HP:0001338) | 1.98878257 |
132 | Poor speech (HP:0002465) | 1.98106028 |
133 | Mitochondrial inheritance (HP:0001427) | 1.97802728 |
134 | Erythroderma (HP:0001019) | 1.97466242 |
135 | Spastic tetraparesis (HP:0001285) | 1.96119037 |
136 | Cystic liver disease (HP:0006706) | 1.96097634 |
137 | Cupped ear (HP:0000378) | 1.95135649 |
138 | Foot dorsiflexor weakness (HP:0009027) | 1.92973492 |
139 | Increased circulating renin level (HP:0000848) | 1.92703054 |
140 | Paralysis (HP:0003470) | 1.90041818 |
141 | White forelock (HP:0002211) | 1.89725470 |
142 | CNS hypomyelination (HP:0003429) | 1.88870197 |
143 | Hypoplasia of the ulna (HP:0003022) | 1.88210696 |
144 | Metabolic alkalosis (HP:0200114) | 1.88133967 |
145 | Progressive inability to walk (HP:0002505) | 1.86443884 |
146 | Keratoconus (HP:0000563) | 1.85905330 |
147 | Increased corneal curvature (HP:0100692) | 1.85905330 |
148 | Chorioretinal atrophy (HP:0000533) | 1.85244143 |
149 | Patchy hypopigmentation of hair (HP:0011365) | 1.85226536 |
150 | Type II lissencephaly (HP:0007260) | 1.84457928 |
151 | Focal seizures (HP:0007359) | 1.84120782 |
152 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.84027488 |
153 | Furrowed tongue (HP:0000221) | 1.83905163 |
154 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83346377 |
155 | Short phalanx of the thumb (HP:0009660) | 1.83085415 |
156 | Porencephaly (HP:0002132) | 1.82370794 |
157 | Premature skin wrinkling (HP:0100678) | 1.81581543 |
158 | Vaginal atresia (HP:0000148) | 1.81512060 |
159 | Abnormality of the nasal septum (HP:0000419) | 1.81246865 |
160 | Hemiparesis (HP:0001269) | 1.80089199 |
161 | Limb dystonia (HP:0002451) | 1.80051409 |
162 | Generalized myoclonic seizures (HP:0002123) | 1.79786030 |
163 | Acute necrotizing encephalopathy (HP:0006965) | 1.79701996 |
164 | Barrel-shaped chest (HP:0001552) | 1.79518416 |
165 | Thyroiditis (HP:0100646) | 1.79423341 |
166 | Progressive macrocephaly (HP:0004481) | 1.78409879 |
167 | Decreased central vision (HP:0007663) | 1.78033991 |
168 | Bowel incontinence (HP:0002607) | 1.77937862 |
169 | Hypoplastic left heart (HP:0004383) | 1.77639181 |
170 | Absent thumb (HP:0009777) | 1.77610935 |
171 | Widely spaced teeth (HP:0000687) | 1.77526726 |
172 | Attenuation of retinal blood vessels (HP:0007843) | 1.77169149 |
173 | Clonus (HP:0002169) | 1.76996831 |
174 | Abnormality of the septum pellucidum (HP:0007375) | 1.76538101 |
175 | Urinary urgency (HP:0000012) | 1.75905803 |
176 | Hypomagnesemia (HP:0002917) | 1.75895243 |
177 | Fused cervical vertebrae (HP:0002949) | 1.75341575 |
178 | Oligodontia (HP:0000677) | 1.74557569 |
179 | Medial flaring of the eyebrow (HP:0010747) | 1.73902558 |
180 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.73133673 |
181 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.73133673 |
182 | Single umbilical artery (HP:0001195) | 1.73133673 |
183 | Mixed hearing impairment (HP:0000410) | 1.72385634 |
184 | Fibular aplasia (HP:0002990) | 1.72360049 |
185 | Morphological abnormality of the middle ear (HP:0008609) | 1.72126246 |
186 | Hyporeflexia of lower limbs (HP:0002600) | 1.71938155 |
187 | Genital tract atresia (HP:0001827) | 1.71896852 |
188 | Dicarboxylic aciduria (HP:0003215) | 1.71794528 |
189 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.71794528 |
190 | Abnormality of the renal collecting system (HP:0004742) | 1.71683750 |
191 | Abnormality of the renal cortex (HP:0011035) | 1.71582924 |
192 | Abnormality of the foot musculature (HP:0001436) | 1.70900002 |
193 | Carpal bone hypoplasia (HP:0001498) | 1.70103905 |
194 | Coronal craniosynostosis (HP:0004440) | 1.68198154 |
195 | Dysdiadochokinesis (HP:0002075) | 1.67472092 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 5.67277570 |
2 | FRK | 5.29269344 |
3 | OXSR1 | 4.50471188 |
4 | EPHB1 | 3.17859253 |
5 | CDK19 | 3.08428746 |
6 | BCR | 3.01133917 |
7 | TAOK3 | 2.70348659 |
8 | TLK1 | 2.52372379 |
9 | CASK | 2.49375833 |
10 | TXK | 2.37265406 |
11 | PRPF4B | 2.35284830 |
12 | WNK4 | 2.27199085 |
13 | PKN1 | 2.22571523 |
14 | LIMK1 | 2.05270276 |
15 | ACVR1B | 2.03622774 |
16 | PNCK | 1.99487064 |
17 | BCKDK | 1.99280695 |
18 | IKBKB | 1.98957839 |
19 | MET | 1.96600580 |
20 | MAPKAPK5 | 1.86843393 |
21 | TNIK | 1.83226728 |
22 | WNK1 | 1.80595863 |
23 | PBK | 1.79198032 |
24 | CSNK1G3 | 1.76451455 |
25 | CSNK1A1L | 1.70391663 |
26 | ICK | 1.63110321 |
27 | CAMK2B | 1.56638386 |
28 | ROCK2 | 1.50006003 |
29 | NEK6 | 1.49278424 |
30 | FGFR2 | 1.46220108 |
31 | MAP3K11 | 1.46163584 |
32 | NTRK1 | 1.43832155 |
33 | MAP3K14 | 1.41854414 |
34 | NME2 | 1.41749049 |
35 | CSNK1G1 | 1.41536408 |
36 | BLK | 1.41396655 |
37 | MAP4K2 | 1.40272336 |
38 | TGFBR2 | 1.39642172 |
39 | CSNK1G2 | 1.38978123 |
40 | UHMK1 | 1.38556418 |
41 | MST4 | 1.38509663 |
42 | FGR | 1.37818796 |
43 | EPHA4 | 1.35428528 |
44 | MARK1 | 1.35003552 |
45 | EPHB2 | 1.34544227 |
46 | ZAK | 1.33943161 |
47 | PAK6 | 1.33022628 |
48 | TESK2 | 1.29363554 |
49 | CAMK2D | 1.28234787 |
50 | SGK494 | 1.23434574 |
51 | SGK223 | 1.23434574 |
52 | TIE1 | 1.22022553 |
53 | ABL2 | 1.19284286 |
54 | DAPK2 | 1.15819138 |
55 | ARAF | 1.15516390 |
56 | MST1R | 1.15023846 |
57 | PRKD2 | 1.13300515 |
58 | INSRR | 1.12848797 |
59 | BMPR1B | 1.12300766 |
60 | EPHA2 | 1.10180299 |
61 | MAP3K13 | 1.05403648 |
62 | NUAK1 | 1.04942837 |
63 | PAK3 | 1.03747557 |
64 | ADRBK1 | 1.03688136 |
65 | MAPK15 | 1.02807443 |
66 | CHUK | 1.01136661 |
67 | CAMKK2 | 1.00934459 |
68 | MATK | 0.98956539 |
69 | TBK1 | 0.96165730 |
70 | CAMK2G | 0.95611102 |
71 | CAMK2A | 0.94986971 |
72 | CDK5 | 0.93908516 |
73 | PHKG1 | 0.93839249 |
74 | PHKG2 | 0.93839249 |
75 | GRK5 | 0.93673733 |
76 | PIM2 | 0.93526898 |
77 | TRPM7 | 0.92107555 |
78 | PRKCE | 0.89777056 |
79 | DYRK2 | 0.88290826 |
80 | CDK14 | 0.88120045 |
81 | MAP3K9 | 0.84917061 |
82 | IKBKE | 0.84569530 |
83 | MAPKAPK3 | 0.82757531 |
84 | RPS6KA6 | 0.80351889 |
85 | PRKCQ | 0.79512909 |
86 | KIT | 0.78965419 |
87 | CSK | 0.77864826 |
88 | IRAK3 | 0.77849388 |
89 | NTRK2 | 0.77180728 |
90 | MAP4K1 | 0.75703035 |
91 | CSF1R | 0.75248820 |
92 | CDK15 | 0.74181671 |
93 | SYK | 0.73288773 |
94 | CDK18 | 0.70908053 |
95 | CLK1 | 0.70727637 |
96 | DYRK3 | 0.68074569 |
97 | PDPK1 | 0.67677036 |
98 | ERBB4 | 0.66994668 |
99 | LYN | 0.66484220 |
100 | GRK7 | 0.65538018 |
101 | CDK11A | 0.64597000 |
102 | MUSK | 0.63343088 |
103 | MARK2 | 0.62504060 |
104 | TGFBR1 | 0.61870299 |
105 | TYRO3 | 0.61748516 |
106 | RPS6KA2 | 0.61566110 |
107 | PRKD3 | 0.61419092 |
108 | MAP3K4 | 0.60827827 |
109 | MAP2K2 | 0.58765654 |
110 | KSR2 | 0.58040892 |
111 | NTRK3 | 0.56757881 |
112 | CDK9 | 0.56401752 |
113 | PRKD1 | 0.55346326 |
114 | RPS6KL1 | 0.54729705 |
115 | RPS6KC1 | 0.54729705 |
116 | MAP2K6 | 0.53692820 |
117 | FYN | 0.53117977 |
118 | SGK2 | 0.51103918 |
119 | LCK | 0.49778513 |
120 | MAPK7 | 0.47824622 |
121 | PLK2 | 0.47595568 |
122 | PRKG1 | 0.46563296 |
123 | STK16 | 0.45915726 |
124 | GRK1 | 0.45565218 |
125 | STK11 | 0.43923385 |
126 | ABL1 | 0.43645447 |
127 | CSNK1D | 0.43544414 |
128 | PINK1 | 0.43440319 |
129 | ITK | 0.43025866 |
130 | CAMK1G | 0.42432808 |
131 | TEC | 0.41344778 |
132 | PIK3CA | 0.41291795 |
133 | NME1 | 0.41135940 |
134 | DDR2 | 0.40872035 |
135 | PRKACB | 0.40698405 |
136 | PRKCA | 0.39987799 |
137 | IGF1R | 0.38861280 |
138 | PRKCH | 0.37871369 |
139 | CDK8 | 0.37779604 |
140 | CSNK1A1 | 0.37741248 |
141 | ADRBK2 | 0.37120397 |
142 | PTK2B | 0.36177377 |
143 | MAPK13 | 0.35475514 |
144 | PDK1 | 0.32799658 |
145 | MAP2K7 | 0.32432978 |
146 | DAPK3 | 0.32270354 |
147 | DYRK1A | 0.31802843 |
148 | RPS6KA5 | 0.31005995 |
149 | PRKCG | 0.30733366 |
150 | BRAF | 0.29406732 |
151 | BMX | 0.29071704 |
152 | PRKACA | 0.27303983 |
153 | WNK3 | 0.25578692 |
154 | SGK1 | 0.25441752 |
155 | MOS | 0.25060840 |
156 | GSK3A | 0.23609748 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.31779034 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.12188746 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.41221909 |
4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.03438832 |
5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.97918735 |
6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.68256279 |
7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.64600468 |
8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.64053299 |
9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.46669201 |
10 | Asthma_Homo sapiens_hsa05310 | 2.37667389 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.24977669 |
12 | Axon guidance_Homo sapiens_hsa04360 | 1.98885814 |
13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.88679269 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.85192265 |
15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.84412899 |
16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.71468161 |
17 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.71467139 |
18 | Protein export_Homo sapiens_hsa03060 | 1.71105526 |
19 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.71067606 |
20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.69426792 |
21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66652875 |
22 | Allograft rejection_Homo sapiens_hsa05330 | 1.66517694 |
23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.63259971 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.62741087 |
25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.59139069 |
26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.58873203 |
27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.57557923 |
28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57490737 |
29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52766539 |
30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52202658 |
31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.51719316 |
32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47536658 |
33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45151460 |
34 | Morphine addiction_Homo sapiens_hsa05032 | 1.44134953 |
35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.44112166 |
36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35399567 |
37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.35008944 |
38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33619350 |
39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.30941544 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27485185 |
41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26805456 |
42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24338493 |
43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.24126116 |
44 | Long-term depression_Homo sapiens_hsa04730 | 1.23020390 |
45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19386493 |
46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16366985 |
47 | Circadian entrainment_Homo sapiens_hsa04713 | 1.16345792 |
48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15009415 |
49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14770561 |
50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12173945 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10039810 |
52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09139073 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08343679 |
54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08231313 |
55 | Tight junction_Homo sapiens_hsa04530 | 1.07864312 |
56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07300398 |
57 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06264478 |
58 | Salivary secretion_Homo sapiens_hsa04970 | 1.03156802 |
59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02120602 |
60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02047558 |
61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97759246 |
62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97166595 |
63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96239359 |
64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95966057 |
65 | Peroxisome_Homo sapiens_hsa04146 | 0.95276387 |
66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94996606 |
67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94868860 |
68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.94428264 |
69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92183260 |
70 | Taste transduction_Homo sapiens_hsa04742 | 0.89524169 |
71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89242754 |
72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88458776 |
73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86941449 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86030134 |
75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85766792 |
76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85330661 |
77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84733008 |
78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83734275 |
79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83067331 |
80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82894656 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.80467362 |
82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79626974 |
83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79249039 |
84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79166742 |
85 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79121630 |
86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78774730 |
87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74497444 |
88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.73476921 |
89 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73288393 |
90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.72720694 |
91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71279051 |
92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70414522 |
93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70057046 |
94 | Renin secretion_Homo sapiens_hsa04924 | 0.69344693 |
95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69225433 |
96 | Phototransduction_Homo sapiens_hsa04744 | 0.69122456 |
97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68999672 |
98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68992911 |
99 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68354446 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67951442 |
101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67620388 |
102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65586613 |
103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64995268 |
104 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64417813 |
105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63215302 |
106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61125697 |
107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61075962 |
108 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60869445 |
109 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60778990 |
110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60223596 |
111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59714254 |
112 | Phagosome_Homo sapiens_hsa04145 | 0.58552989 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.57698002 |
114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57066917 |
115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55860403 |
116 | Gap junction_Homo sapiens_hsa04540 | 0.55331357 |
117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55285512 |
118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54419917 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53958405 |
120 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52898871 |
121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52397735 |
122 | Insulin secretion_Homo sapiens_hsa04911 | 0.52010257 |
123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50514910 |
124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50375124 |
125 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49974877 |
126 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49508141 |
127 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49320856 |
128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47614899 |
129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47469373 |
130 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47312926 |
131 | Prion diseases_Homo sapiens_hsa05020 | 0.47038871 |
132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47033177 |
133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46995025 |
134 | Malaria_Homo sapiens_hsa05144 | 0.46718659 |
135 | Melanogenesis_Homo sapiens_hsa04916 | 0.45518104 |
136 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45284818 |
137 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44237340 |
138 | Lysosome_Homo sapiens_hsa04142 | 0.43737517 |
139 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43266548 |
140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41929509 |
141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41712918 |
142 | RNA polymerase_Homo sapiens_hsa03020 | 0.40847303 |
143 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40317568 |
144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40284224 |
145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39534156 |
146 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39041074 |
147 | RNA degradation_Homo sapiens_hsa03018 | 0.38784511 |
148 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38031071 |
149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37807419 |
150 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37228684 |
151 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36809328 |
152 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.35192521 |